Depression And Alzheimer's Treatments At A Crossroads

2025-01-12 21:58:34 source:lotradecoin privacy policy explained category:Stocks

Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Stocks

Recommend

Albertsons gives up on Kroger merger and sues the grocery chain for failing to secure deal

Albertsons is giving up on its merger with Kroger a day after it was rejected in two courts and it i

Red Sox say Tim Wakefield is in treatment, asks for privacy after illness outed by Schilling

BOSTON (AP) — The Boston Red Sox say announcer and former knuckleballer Tim Wakefield is undergoing

Red Sox say Tim Wakefield is in treatment, asks for privacy after illness outed by Schilling

BOSTON (AP) — The Boston Red Sox say announcer and former knuckleballer Tim Wakefield is undergoing